Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
暂无分享,去创建一个
R. Carare | S. D. Preston | R. Weller | M. Subash | Roxana O Carare | Roy O Weller | Stephen D Preston | Malavika Subash
[1] P. Knopf,et al. Drainage of Brain Extracellular Fluid into Blood and Deep Cervical Lymph and its Immunological Significance , 1992, Brain pathology.
[2] F. LaFerla,et al. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.
[3] Eric E. Smith,et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy , 2005, Annals of neurology.
[4] M. Esiri,et al. Cerebral amyloid angiopathy in dementia and old age. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[5] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[6] Mathias Jucker,et al. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. , 2006, Brain pathology.
[7] Brian J Bacskai,et al. Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.
[8] B. Sommer,et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Strümpell,et al. Zeitschrift für die gesamte Neurologie und Psychiatrie , 1922, Deutsche Zeitschrift für Nervenheilkunde.
[10] A. Palsdottir,et al. Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. , 2006, Brain pathology.
[11] M. Rausch,et al. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis , 2004, The European journal of neuroscience.
[12] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[13] S. Love,et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .
[14] H. Braak,et al. Two Types of Sporadic Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.
[15] C. Nicholson,et al. Diffusion in brain extracellular space. , 2008, Physiological reviews.
[16] R O Weller,et al. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.
[17] G. Glenner,et al. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. , 1984, Applied pathology.
[18] T. Beach. Physiologic Origins of Age-Related β-Amyloid Deposition , 2008, Neurodegenerative Diseases.
[19] M. Frosch,et al. The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .
[20] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[21] K. Jellinger,et al. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study , 2004, Acta Neuropathologica.
[22] B. Dubois,et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization , 2003, Neurology.
[23] R. Carare,et al. Lymphatic drainage of the brain and the pathophysiology of neurological disease , 2008, Acta Neuropathologica.
[24] T. Beach,et al. Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease , 2003, Molecular medicine.
[25] M. Frosch,et al. The cerebral beta-amyloid angiopathies: hereditary and sporadic. , 2006, Brain pathology.
[26] Dietmar Rudolf Thal,et al. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances , 2009, Neurobiology of Aging.
[27] I. Ferrer,et al. Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis , 2006 .
[28] D. Zawieja,et al. Molecular Regulation of Lymphatic Contractility , 2008, Annals of the New York Academy of Sciences.
[29] Masanori Kato,et al. Relative paucity of tau accumulation in the small areas with abundant Aβ42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology , 2006, Acta Neuropathologica.
[30] C. Glabe,et al. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction , 2009, Neurobiology of Disease.
[31] R. Carare,et al. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .
[32] T. Mazel,et al. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Graham,et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. , 1999, Journal of neuropathology and experimental neurology.
[34] Yu-Min Kuo,et al. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.
[35] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[36] O. Wiestler,et al. Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.
[37] G. Plant,et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.
[38] V. Perry,et al. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. , 2006, Journal of theoretical biology.
[39] Mathias Jucker,et al. Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .
[40] I. Ferrer,et al. A&bgr; Species Removal After A&bgr;42 Immunization , 2006, Journal of neuropathology and experimental neurology.
[41] Eric E. Smith,et al. &bgr;-Amyloid, Blood Vessels, and Brain Function , 2009, Stroke.
[42] R. Clapham,et al. Cervical lymph nodes are found in direct relationship with the internal carotid artery: Significance for the lymphatic drainage of the brain , 2009, Clinical anatomy.
[43] H. Staunton,et al. Peripheral Nerve Amyloidosis , 1996, Brain pathology.
[44] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[45] S. Love,et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. , 2005, Brain : a journal of neurology.
[46] R O Weller,et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.
[47] Y. Ihara,et al. Amyloid β‐proteins 1—40 and 1—42(43) in the soluble fraction of extra‐ and intracranial blood vessels , 1995 .
[48] R. Carare,et al. Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis. , 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.
[49] T. Révész,et al. Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease , 2008, Neuropathology and applied neurobiology.
[50] W. Scholz. Studien zur Pathologie der Hirngefäße II , 1938 .
[51] R. Weller,et al. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease Pro-CAA position statement , 2004, Neurobiology of Aging.
[52] Seth Love,et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.
[53] J. Wegiel,et al. Beta-amyloid formation by myocytes of leptomeningeal vessels. , 1994, Acta neuropathologica.
[54] N. Joan Abbott,et al. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology , 2004, Neurochemistry International.
[55] E. Masliah,et al. Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.
[56] H. Budka,et al. Molecular Pathology of Human Prion Diseases , 2009, International journal of molecular sciences.
[57] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[58] D. Holtzman,et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.
[59] R. Barbour,et al. Immunotherapy Reduces Vascular Amyloid-β in PDAPP Mice , 2008, The Journal of Neuroscience.
[60] D. Wilcock,et al. Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage , 2004, Journal of Neuroinflammation.
[61] S. Love,et al. Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy , 2006, Journal of neuropathology and experimental neurology.
[62] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[63] L. Mucke,et al. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.
[64] D. Walsh,et al. Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.
[65] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[66] R. Weller,et al. A role for cerebrovascular disease in determining the pattern of β‐amyloid deposition in Alzheimer's disease , 2002 .
[67] J. McLaurin,et al. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy , 2009, Proceedings of the National Academy of Sciences.
[68] Eric E. Smith,et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy , 2008, Neurology.
[69] S. Love,et al. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. , 2009, Frontiers in bioscience.
[70] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[71] L. Lue,et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.
[72] D. Graham,et al. The Apolipoprotein E ∈2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage , 1999 .
[73] E. Forman,et al. Research as Therapy , 1991 .
[74] M. Staufenbiel,et al. Extracellular amyloid formation and associated pathology in neural grafts , 2003, Nature Neuroscience.
[75] Ian G. McKeith,et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.
[76] S. D. Preston,et al. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain , 2003, Neuropathology and applied neurobiology.
[77] D. Holtzman,et al. Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[78] C. Patlak,et al. Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.
[79] D. Holtzman,et al. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. , 2007, The American journal of pathology.
[80] Dietmar Rudolf Thal,et al. Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease , 2008, Acta Neuropathologica.
[81] L. Pantoni. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. , 2008, Stroke.